Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barbora Jacobsen
Observed name:
B. Jacobsen
Institutions:
Direktoratet for medisinske produkter,
St Olav's University Hospital
Observed institutions:
Direktoratet for medisinske produkter,
St Olav's University Hospital
ORCID:
0009-0000-7540-5983
Observed ORCID:
0009-0000-7540-5983
OpenAlex ID:
A5019244963
The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti‐D prophylaxis
2021
·
Kirsten Sørensen
, Mette S. Bævre
, et al.
·
Transfusion Medicine
·
13
Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping
2023
·
Monica Stensrud
, Mette Silihagen Bævre
, et al.
·
Fetal Diagnosis and Therapy
·
7
A fatal case of acute hemolytic transfusion reaction caused by anti-Wr a : case report and review of the literature
2021
·
A. Espinosa
, L.J. Garvik
, et al.
·
Immunohematology
·
4
Evaluation of the cytokine stability in serum for the production of allogeneic serum eye drops
2026
·
Barbora Jacobsen
, Aurora Espinosa
·
Transfusion and Apheresis Science
·
1
PDF
Practices in platelet production: A Nordic perspective (2018–2022)
2025
·
Aseel Alshamari
, Tynngård Nahreen
, et al.
·
Vox Sanguinis
·
1
Evidensbasert transfusjonspraksis ved jernmangelanemi
2023
·
Aurora Espinosa
, Astrid Aandahl
, et al.
·
Tidsskrift for Den norske legeforening
·
1
PDF
International Haemovigilance Seminar 2026, Rome, 18-20 March 2026.
2026
·
Simon Benson
, Shruthi Naryan
, et al.
·
PubMed
EP1T2_4 Benchmarking Regional and National Blood Product Utilization : A Comparative Study Between Spain and Norway
2026
·
A. Espinosa
, A. Aandahl
, et al.
·
Research and Practice in Thrombosis and Haemostasis
Clinical Transfusion Handbook updated
2026
·
Tor Audun Hervig
, Mirjana Grujic Arsenovic
, et al.
·
Tidsskrift for Den norske legeforening
PDF
MRD-Negative Response After VRd induction, HD-ASCT, and VRd consolidation in Transplant-Eligible Newly Diagnosed Multiple Myeloma: Phase 2 REMNANT Study with Broad Inclusion Criteria
2026
·
Frida Bugge Askeland
, Anne-Marie Rasmussen
, et al.
·
Research Square
PDF
Transfusion reactions after whole blood transfusion in Norway, 2021–2024: A report from the Norwegian Hemovigilance program
2026
·
Bjarte Skoe Erikstein
, Thomas Larsen Titze
, et al.
·
Transfusion
Myter og fakta om plasmatransfusjon
2025
·
Aurora Espinosa
, Astrid Aandahl
, et al.
·
Tidsskrift for Den norske legeforening
PDF
Show more works
View as search
Works count:
12
Citation count:
27
H-index:
3
I10-index:
1
Year
Topic
Type